25E-NBOH Facts
Psychedelic;
Description
25E-NBOH (2C-E-NBOH) is a synthetic psychedelic of the phenethylamine class. It activates serotonin receptors in the brain,[1] producing the visual distortions and cognitive shifts characteristic of classical psychedelics.
Subjective effects include geometric visual patterns, brightened colors, cognitive stimulation, analytical clarity, and heightened verbal fluency. The experience is unusually lucid — perception becomes dramatically altered while the capacity to think and speak stays largely intact, distinguishing it from the cognitive dissolution characteristic of high-dose tryptamines.
25E-NBOH does not produce physical dependence, but its toxic dose in humans is unknown, and at least one source references fatal cases.[2] The primary dangers are cardiovascular: blood vessel constriction can drive dangerous blood pressure elevation, and the class carries documented risk of seizures and fatal overheating.[3]
Dose and durationby route · individual sensitivity varies
Starts in 15 – 45 minLasts 4 – 6 hoursAfter-effects 2 – 6 hours
Body and dependence
- Acute toxicity
- Moderate
- Chronic toxicity
- Low
- Physical dependence
- None
- Psychological dependence
- Negligible
- Withdrawal
- None recorded
- Compulsive redosing
- Negligible
Tolerance
- Builds
- Rapid
- Fully resets after
- 14 days
- Carries over to
- LSD;
psilocybin; mescaline; DMT; DOx series; 25x-NBOMe compounds; 25x-NBOH compounds
Effectslikely at a common dose
- Perception
- Color enhancement;
Visual drifting; Color alteration; Geometry; Visual breathing; +28 possible, including Spatial disorientation, Visual haze / noise, Vestibular distortion - Body
- Pupil dilation;
Body scan awareness; +31 possible, including Vasoconstriction, Muscle tension, Temperature dysregulation - Thinking
- none likely · 34 possible, including Memory suppression, Cognitive impairment, Decision impairment
- Feeling
- none likely · 8 possible, including Emotional lability, Anxiety, Paranoia
- Self
- none likely · 10 possible, including Derealization, Depersonalization
- Time
- Time alteration;
+4 possible, including Temporal disorientation - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 5 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
Most difficulty is psychological (intense fear, panic, confusion) and passes with calm support — the signs below mean seek emergency help:
- Very high body temperature; hot, dry skin
- Seizures
- Chest pain; fast or irregular heartbeat
- Severe muscle rigidity, tremor, or twitching (possible serotonin syndrome)
- Cold, pale, or blue fingers/toes — severe vasoconstriction (notably NBOMe / DOx)
- Persistent vomiting; unconsciousness; uncontrollable agitation or risk of self-harm
What to do
- Stay calm and reassure — remind them they took a drug and the effect will pass
- Move to a calm, quiet, safe space with low light; reduce noise and sensory input
- Keep them from harm — they may act on fear or confusion; stay with them, don't leave them alone
- Talk them down gently; don't grab or restrain unless they're in danger
- For the medical signs above (overheating, seizure, chest pain, vasoconstriction, unresponsive) call emergency services
- If overheating, cool the body; be ready to give rescue breaths / CPR
The experience is time-limited and usually resolves with calm reassurance in a safe setting — psychological first aid, not medication. Serious physical harm is uncommon for classic psychedelics (LSD, psilocybin) but real for some potent phenethylamines (NBOMe, DOx), where hyperthermia, seizures, and vasoconstriction warrant emergency care.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^Munir DD, Shetty RA, Gatch MB, Sumien N, Hill RD, Priddy JA, Forster MJ (2025) Locomotor and discriminative stimulus effects of NBOH hallucinogens in rodents — Behavioural Pharmacology doi:10.1097/fbp.0000000000000802
- [2]^Xiang J, Wen D, Zhai W, Zhao J, Xiang P, Ma C, Shi Y (2024) Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes. — Journal of Pharmaceutical and Biomedical Analysis doi:10.1016/j.jpba.2024.116020
- [3]^Halberstadt AL (2017) Pharmacology and Toxicology of N-Benzylphenethylamine (NBOMe) Hallucinogens — Current Topics in Behavioral Neurosciences doi:10.1007/7854_2016_64